The global genitourinary drugs market is accounted for USD 28,200 million expected  and expected to register CAGR ~1.65% during the forecast period (2018–2023). Genitourinary disorders are caused by damage to urinal or genital part of the human body. Kidney, bladder, ureter and urethra are parts of genitourinary system, genitourinary drugs are used to treat the ...